Page last updated: 2024-09-04

vx 497 and odanacatib

vx 497 has been researched along with odanacatib in 1 studies

Compound Research Comparison

Studies
(vx 497)
Trials
(vx 497)
Recent Studies (post-2010)
(vx 497)
Studies
(odanacatib)
Trials
(odanacatib)
Recent Studies (post-2010) (odanacatib)
253714827128

Protein Interaction Comparison

ProteinTaxonomyvx 497 (IC50)odanacatib (IC50)
Cathepsin L2Homo sapiens (human)0.762
Procathepsin LHomo sapiens (human)3.919
Cathepsin BHomo sapiens (human)1.3613
Cathepsin SHomo sapiens (human)0.197
Cathepsin KHomo sapiens (human)0.0005
Cathepsin KOryctolagus cuniculus (rabbit)0.001
Cathepsin FHomo sapiens (human)0.795

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

1 other study(ies) available for vx 497 and odanacatib

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023